Abstract

Caveolin-1 (Cav-1) is one of the key molecules to modulate collagen metabolism in the skin. This study aimed to unravel the relationship between Cav-1 and collagen levels in the aged skin, and also to evaluate a new role of anti-Cav-1 agent as a collagen-modulating agent. A negative correlation between Cav-1 and collagen I (COL I) was detected in chronologically aged skin of humans and mice, which was further confirmed by Cav-1 knock-down or knock-out experiments. Next, we tested whether methyl-β-cyclodextrin (MβCD) as a chemical Cav-1 inhibitor could be developed as a collagen-modulating agent in the skin. Testing different conditions of MβCD injection via the intra-dermal route revealed that 2.5% MβCD administered twice per week for two months showed a potent COL I-up-regulating activity, leading to the increase of skin thickness (P < 0.05) without adverse reactions such as skin fibrosis. In human dermal fibroblasts, MβCD treatment induced up-regulated COL I and down-regulated Cav-1, supporting the results of mouse experiments. Collectively, MβCD has a COL I-enhancing activity in chronologically-aged skin, where Cav-1 acts as a brake in COL I expression, suggesting its potential role for an anti-aging agent.

Highlights

  • Caveolins are principal integral membrane proteins of caveolae, which comprise at least four proteins – caveolin-1α, 1β (21–24 kDa), and -2 (20 kDa) – that are co-expressed to form hetero-oligomeric complex in many cells, whereas caveolin-3 (18 kDa) is muscle specific [13]

  • This study demonstrates that decreased collagen I (COL I) level in chronologically-aged skin is closely related with elevated Cav-1 level

  • There was a negative correlation between expression levels of Cav-1 and COL I in chronologically-aged human and mouse skin in vivo

Read more

Summary

Introduction

Caveolins are principal integral membrane proteins of caveolae, which comprise at least four proteins – caveolin-1α, 1β (21–24 kDa), and -2 (20 kDa) – that are co-expressed to form hetero-oligomeric complex in many cells, whereas caveolin-3 (18 kDa) is muscle specific [13] Besides their structural role, caveolins have a gatekeeping role in modulating various signaling molecules localized to the membrane component [4, 5]. Cav-1 was reported to exert an inhibitory activity by modulating transforming growth factor- β (TGF-β) signaling through its participation in TGF-β receptor (TβR) internalization [10] These studies suggest that Cav-1 plays a brake role in collagen expression in the skin or DFs. In contrast, Cav-1 was reported to play an accelerator role by up-regulating collagen I (COL I) via the TGF-β pathway in DFs or Cav-1 transgenic mice [13, 14]. In relation with skin aging, reduced www.impactjournals.com/oncotarget

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.